Harvard Medical School Beth Israel Deaconess Medical Center is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Harvard Medical School Beth Israel Deaconess Medical Center has participated in 2 clinical trials.
Therapeutic areas: Glioblastoma Multiforme, Type 2 Diabetes Mellitus, Chronic Kidney Disease.
Sponsors: Precision Life Sciences Group, Concert Pharmaceuticals.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Harvard Medical School Beth Israel Deaconess Medical Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Harvard Medical School Beth Israel Deaconess Medical Center has 2 clinical trials on record. Their work covers Glioblastoma Multiforme, Type 2 Diabetes Mellitus, Chronic Kidney Disease.
Harvard Medical School Beth Israel Deaconess Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.